Kymera Therapeutics, Inc. (KYMR)

87.71 +1.57 (+1.82%) USD  |  NASDAQ  |  Apr 17, 16:00
87.67 -0.04 (-0.05%) After-Hours: 20:00
More

Kymera Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. --
Regeneron Pharmaceuticals, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. --